MakroCare — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

MakroCare is a private, revenue-generating services company that provides integrated clinical research and regulatory affairs solutions powered by proprietary technology. It serves as a strategic partner to life sciences companies, aiming to reduce trial timelines and costs through data-driven insights and process automation. The company's focus on digital health and AI positions it within the growing market for tech-enabled clinical trial services. Its established presence since 2008 suggests a mature service portfolio and a client base in the biopharma sector.

Digital HealthAI / Machine Learning

Technology Platform

Proprietary software platforms leveraging AI and machine learning for clinical trial optimization, regulatory information management, data analytics, and risk-based monitoring.

Opportunities

The growing adoption of decentralized clinical trials and AI-driven drug development creates strong demand for integrated tech-enabled services.

Increasing regulatory complexity and globalization of markets expands the need for sophisticated regulatory outsourcing and submission platforms.

Risk Factors

Faces intense competition from large global CROs with vast resources and agile tech startups.

Revenue is susceptible to biopharma R&D spending cycles and client concentration.

Execution risk in developing and integrating complex, compliant technology platforms.

Competitive Landscape

Competes in the fragmented Clinical Research Organization (CRO) and regulatory services market against giants like IQVIA, ICON, and Parexel, as well as numerous niche and tech-focused service providers. Differentiation relies on demonstrating superior efficiency gains from its integrated technology and service model.

More companies in Small Molecule Drugs →More companies in United States →